Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

Parry MG, Cowling TE, Sujenthiran A, Nossiter J, Berry B, Cathcart PJ, Aggarwal A, Payne H, van der Meulen J, Clarke NW and Gnanapragasam VJ